BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19135901)

  • 1. Neurobeachin (NBEA) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myeloma.
    O'Neal J; Gao F; Hassan A; Monahan R; Barrios S; Kilimann MW; Lee I; Chng WJ; Vij R; Tomasson MH
    Exp Hematol; 2009 Feb; 37(2):234-44. PubMed ID: 19135901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormality.
    Nagoshi H; Taki T; Hanamura I; Nitta M; Otsuki T; Nishida K; Okuda K; Sakamoto N; Kobayashi S; Yamamoto-Sugitani M; Tsutsumi Y; Kobayashi T; Matsumoto Y; Horiike S; Kuroda J; Taniwaki M
    Cancer Res; 2012 Oct; 72(19):4954-62. PubMed ID: 22869583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial deletions at the long arm of chromosome 13 may be as common as monosomies in multiple myeloma. A genotypic study.
    Nomdedéu JF; Lasa A; Ubeda J; Saglio G; Bellido M; Casas S; Carnicer MJ; Aventín A; Sureda A; Sierra J; Baiget M
    Haematologica; 2002 Aug; 87(8):828-35. PubMed ID: 12161359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy.
    Fonseca R; Oken MM; Harrington D; Bailey RJ; Van Wier SA; Henderson KJ; Kay NE; Van Ness B; Greipp PR; Dewald GW
    Leukemia; 2001 Jun; 15(6):981-6. PubMed ID: 11417487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion mapping of chromosome 13q in head and neck squamous cell carcinoma in Indian patients: correlation with prognosis of the tumour.
    Sabbir MG; Roy A; Mandal S; Dam A; Roychoudhury S; Panda CK
    Int J Exp Pathol; 2006 Apr; 87(2):151-61. PubMed ID: 16623759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance.
    Königsberg R; Ackermann J; Kaufmann H; Zojer N; Urbauer E; Krömer E; Jäger U; Gisslinger H; Schreiber S; Heinz R; Ludwig H; Huber H; Drach J
    Leukemia; 2000 Nov; 14(11):1975-9. PubMed ID: 11069034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcome.
    Puiggros A; Venturas M; Salido M; Blanco G; Fernandez-Rodriguez C; Collado R; Valiente A; Ruiz-Xivillé N; Carrió A; Ortuño FJ; Luño E; Calasanz MJ; Ardanaz MT; Piñán MÁ; Talavera E; González MT; Ortega M; Marugán I; Ferrer A; Gimeno E; Bellosillo B; Delgado J; Hernández JÁ; Hernández-Rivas JM; Espinet B; ;
    Genes Chromosomes Cancer; 2014 Sep; 53(9):788-97. PubMed ID: 24915757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neurobeachin gene (Nbea) identifies a new region of homology between mouse central chromosome 3 and human chromosome 13q13.
    Gilbert DJ; Engel H; Wang X; Grzeschik KH; Copeland NG; Jenkins NA; Kilimann MW
    Mamm Genome; 1999 Oct; 10(10):1030-1. PubMed ID: 10501977
    [No Abstract]   [Full Text] [Related]  

  • 9. Delineation of the minimal region of loss at 13q14 in multiple myeloma.
    Elnenaei MO; Hamoudi RA; Swansbury J; Gruszka-Westwood AM; Brito-Babapulle V; Matutes E; Catovsky D
    Genes Chromosomes Cancer; 2003 Jan; 36(1):99-106. PubMed ID: 12461754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression and single nucleotide polymorphism array analyses of spindle cell lipomas and conventional lipomas with 13q14 deletion.
    Bartuma H; Nord KH; Macchia G; Isaksson M; Nilsson J; Domanski HA; Mandahl N; Mertens F
    Genes Chromosomes Cancer; 2011 Aug; 50(8):619-32. PubMed ID: 21563233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurobeachin gene spans the common fragile site FRA13A.
    Savelyeva L; Sagulenko E; Schmitt JG; Schwab M
    Hum Genet; 2006 Jan; 118(5):551-8. PubMed ID: 16244873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between chromosome 13q14 deletion and 1q abnormality in multiple myeloma].
    Chen LJ; Li JY; Zhu Y; Wang XW; Qiu HR; Yang RF; Xu W; Xu JR; Lu H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Feb; 26(1):102-5. PubMed ID: 19199264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4q loss is potentially an important genetic event in MM tumorigenesis: identification of a tumor suppressor gene regulated by promoter methylation at 4q13.3, platelet factor 4.
    Cheng SH; Ng MH; Lau KM; Liu HS; Chan JC; Hui AB; Lo KW; Jiang H; Hou J; Chu RW; Wong WS; Chan NP; Ng HK
    Blood; 2007 Mar; 109(5):2089-99. PubMed ID: 17077331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 13q13.3 microdeletion associated with apparently balanced translocation of 46,XX,t(7;13) suggests NBEA involvement.
    Miura M; Ishiyama A; Nakagawa E; Sasaki M; Kurosawa K; Inoue K; Goto YI
    Brain Dev; 2020 Sep; 42(8):581-586. PubMed ID: 32507666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic and Clinicopathologic Features of Primary Myelofibrosis With Isolated 13q Deletion.
    Mehrotra M; Patel KP; Chen T; Miranda RN; Wang Y; Zuo Z; Muddasani R; Mishra BM; Abraham R; Luthra R; Lu G
    Clin Lymphoma Myeloma Leuk; 2015 Aug; 15(8):496-505.e1-2. PubMed ID: 26027540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytogenetic abnormality of chromosome 13q14 in 112 patients with multiple myeloma detected by using LSI-RB1 and LSI-D13S319 probes].
    Li F; Hu LP; An G; Xu Y; Wang YY; Xing LJ; Yi SH; Xie ZQ; Qiu LG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):917-21. PubMed ID: 22931654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of standard prognostic factors with the deletion of 13q14 detected by interphase fluorescence in situ hybridization on separated and unseparated bone marrow cells in multiple myeloma].
    Smejkalová J; Vranová V; Oltová A; Kuglík P; Filková H; Heinigová J; Kovárová L; Adam Z; Krejcí M; Pour L; Büchler T; Svobodník A; Vostrejsová S; Kalábová V; Vorlícek J; Penka M; Hájek R
    Cas Lek Cesk; 2005; 144(7):483-8. PubMed ID: 16161543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of RB1 deletions by fluorescence in situ hybridization in malignant hematologic disorders.
    Juneau AL; Kaehler M; Christensen ER; Schad CR; Zinsmeister AR; Lust J; Hanson C; Dewald GW
    Cancer Genet Cytogenet; 1998 Jun; 103(2):117-23. PubMed ID: 9614909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clustering of deletions on chromosome 13 in benign and low-malignant lipomatous tumors.
    Dahlén A; Debiec-Rychter M; Pedeutour F; Domanski HA; Höglund M; Bauer HC; Rydholm A; Sciot R; Mandahl N; Mertens F
    Int J Cancer; 2003 Feb; 103(5):616-23. PubMed ID: 12494468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.